Interact to see
Advertisement
Advertisement
MEDEX vs REBAX
MEDEX vs REBAX Comparison
Open Charts MEDEX vs REBAX
MFS Emerging Markets Debt R2
Price$12.44
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.49B
Columbia Emerging Markets Bond A
Price$9.87
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets331.38M
MEDEX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDEX vs. REBAX commentary
Aug 16, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDEX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDEX has more cash in the bank: 7.49B vs. REBAX (331M). MEDEX pays higher dividends than REBAX: MEDEX (5.38) vs REBAX (5.03). MEDEX was incepted earlier than REBAX: MEDEX (17 years) vs REBAX (20 years). MEDEX (1.32) is less costly to investors than REBAX (1.13). MEDEX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDEX has a lower initial minimum investment than REBAX: MEDEX (0) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 8.43 vs. MEDEX (7.87). REBAX (7.96) and MEDEX (7.87) have equivalent 5 years return.
| MEDEX | REBAX | MEDEX / REBAX | |
| Total Expense Ratio | 1.31 | 1.13 | 116% |
| Annual Report Gross Expense Ratio | 1.32 | 1.13 | 117% |
| Fund Existence | 17 years | 20 years | - |
| Gain YTD | 6.585 | 7.578 | 87% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.49B | 331M | 2,262% |
| Annual Yield % from dividends | 5.38 | 5.03 | 107% |
| Returns for 1 year | 7.87 | 8.43 | 93% |
| Returns for 3 years | 24.07 | 23.38 | 103% |
| Returns for 5 years | 7.87 | 7.96 | 99% |
| Returns for 10 years | 39.04 | 41.08 | 95% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers